CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 152 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $163,793,718 | +79.5% | 4,263,241 | +8.1% | 0.01% | +66.7% |
| Q1 2023 | $91,269,778 | -11.9% | 3,942,539 | -0.3% | 0.00% | 0.0% |
| Q4 2022 | $103,614,216 | +44.3% | 3,954,741 | +8.3% | 0.00% | +50.0% |
| Q3 2022 | $71,785,000 | +23.2% | 3,651,299 | +9.6% | 0.00% | 0.0% |
| Q2 2022 | $58,279,000 | +16.6% | 3,332,130 | +9.1% | 0.00% | +100.0% |
| Q1 2022 | $49,980,000 | +2.6% | 3,054,997 | +2.2% | 0.00% | 0.0% |
| Q4 2021 | $48,733,000 | +50.5% | 2,987,931 | +17.8% | 0.00% | 0.0% |
| Q3 2021 | $32,375,000 | -7.2% | 2,537,226 | +2.7% | 0.00% | 0.0% |
| Q2 2021 | $34,883,000 | +59.5% | 2,470,469 | +75.5% | 0.00% | 0.0% |
| Q1 2021 | $21,870,000 | -2.1% | 1,407,336 | -0.1% | 0.00% | 0.0% |
| Q4 2020 | $22,336,000 | – | 1,408,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |